Vortrag
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Country-Specific Baseline Characteristics
Speaker
Vortrag
The Real-World Observational Prospective Study of Health Outcomes with Dulaglutide and Liraglutide in Type 2 Diabetes Patients (TROPHIES): Design and Baseline Characteristics
Autor:in
Vortrag
Preferences for profiles of Dulaglutide and Semaglutide, two injectable GLP-1 receptor agonists, among injection-naïve patients with type 2 diabetes in Germany
Autor:in